Steward Partners Investment Advisory, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,029
-56.2%
500.0%0.00%
Q2 2023$2,351
+12.1%
500.0%0.00%
Q1 2023$2,098
-14.1%
50
-21.9%
0.00%
Q4 2022$2,441
+22.0%
64
+28.0%
0.00%
Q3 2022$2,0000.0%500.0%0.00%
Q2 2022$2,0000.0%500.0%0.00%
Q1 2022$2,000
-60.0%
50
-56.5%
0.00%
Q4 2021$5,0000.0%1150.0%0.00%
Q3 2021$5,000
-28.6%
1150.0%0.00%
Q2 2021$7,000
-100.0%
115
-50.0%
0.00%
Q1 2021$17,216,000
+172060.0%
230
+100.0%
0.00%
Q4 2020$10,000
-23.1%
115
-46.5%
0.00%
Q3 2020$13,000
+44.4%
2150.0%0.00%
Q2 2020$9,000
+50.0%
2150.0%0.00%
Q1 2020$6,0000.0%215
+133.7%
0.00%
Q4 2019$6,000
-64.7%
92
-24.6%
0.00%
-100.0%
Q3 2019$17,0000.0%122
+28.4%
0.00%0.0%
Q2 2019$17,000
+30.8%
950.0%0.00%0.0%
Q3 2018$13,000
-13.3%
950.0%0.00%0.0%
Q2 2018$15,0000.0%950.0%0.00%0.0%
Q1 2018$15,000
+275.0%
95
+216.7%
0.00%
Q4 2017$4,000300.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 409,000$17,399,0004.82%
Palo Alto Investors LP 781,730$33,255,0002.12%
DAFNA Capital Management LLC 180,306$7,670,0001.93%
Boxer Capital, LLC 1,094,000$46,539,0001.81%
Deep Track Capital, LP 500,000$21,270,0001.50%
Bellevue Group AG 3,228,004$137,319,0001.42%
EcoR1 Capital, LLC 940,636$40,015,0001.28%
Deep Track Capital, LP 400,000$17,016,0001.20%
Artal Group S.A. 1,000,000$42,540,0001.15%
SECTOR GAMMA AS 98,904$4,207,0000.99%
View complete list of SAGE THERAPEUTICS INC shareholders